C. Schaefer, D. Hannemann, R. Meister, E. Elefant, W. Paulus et al., et al Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study, Thromb Haemost, vol.95, pp.949-957, 2006.

C. Yaakob, C. Dzarr, A. Ismail, A. , Z. Nik-lah et al., Anticoagulant therapy for deep vein thrombosis in pregnancy (review)

C. Chauleur, T. Raia, and C. Gris, Antithrombotic therapy and pregnancy PresseMed, Septembre, vol.42, issue.9, pp.1251-1258, 2013.

R. Tooher, S. Gates, T. Dowswell, and L. Davis, Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period (review)

A. Duhl, M. Paidas, S. Ural, W. Branch, H. Casele et al., Antithrombotic therapy and pregnancy : consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes, American Journal of Obstetrics & Gynecology, vol.197, p.457, 2007.

S. Bates, I. Greer, S. Middeldorp, D. Veenstra, A. Prabulos et al., Antithrombotic therapy and prevention of thrombosis, 9 th ed : American college of chest physicians evidence-based clinical practice guidelines Chest, Février, vol.141, issue.2, pp.691-736, 2012.

I. Greer and A. Thomson, Management of venous thromboembolism in pregnancy Best practice and research clinical obstetrics and gynaecology, pp.583-603, 2001.

K. Toyoda, Antithrombotic Therapy for Pregnant Women, Neurologia medico-chirurgica, vol.53, issue.8, pp.526-530, 2013.
DOI : 10.2176/nmc.53.526

K. Hooman, B. Babak, S. Nandita, D. A. Richard, B. Mitchell et al., Risk of a thrombotic event after the 6-week postpartum period, The New England Journal of Medicine, vol.13, issue.02, pp.10-1056, 2014.

K. Rova, Venous thromboembolism in relation to in??vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles, Fertility and Sterility, vol.97, issue.1, pp.95-100, 2012.
DOI : 10.1016/j.fertnstert.2011.10.038